Monte Rosa Therapeutics Inc
NASDAQ:GLUE 4:00:00 PM EDT
| Market Cap (Intraday) | 290.93M |
| Current PE | 47.28 |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.66 |
| 50-Day MA | $4.53 |
| 200-Day MA | $5.98 |
Monte Rosa Therapeutics Inc Stock, NASDAQ:GLUE
321 Harrison Avenue, Suite 900, Boston, Massachusetts 02118
United States of America
Phone: +1.617.949.2643
Number of Employees: 133
Description
Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.